Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
In the VERROUREA study, there were two cases of an abnormal increase in TCA. In theory no
leakage of the lock into the bloodstream should have been seen. Lock leakage could have
particularly serious, and especially clinical, repercussions in these patients who already
have a high risk of haemorrhage given the numerous associated comorbidities. The aim of this
study is to investigate the leakage of locks into the bloodstream by measuring, before and
after injection of the lock, the evolution of haemostasis tests and calcaemia. The findings
will complete safety data already collected in the VERROU REA study.